Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.
Urgent Questions aren't included in the Question and Answers search. There is a SPICe fact sheet listing Urgent and emergency questions.
Displaying 48919 questions Show Answers
To ask the Scottish Government what its response is to reports that foster carers in Glasgow have not received a pay increase since 2009; what its position is on whether this can be considered fair pay, and, if it considers this is not the case, what steps it can take to address the matter.
To ask the Scottish Government what assessment it has made of the economics of processing Scotland’s scrap steel domestically.
To ask the Scottish Government whether it will provide an update on its discussions with the British Standards Institute regarding the timeline for establishing the proposed Scottish Technical Group, to help ensure that PAS regulations can be tailored for rural and coastal housing stock, climate and geography.
To ask the Scottish Government what assessment it has made of the economics of electric arc furnaces in Scotland.
To ask the Scottish Government how it plans to provide access for patients with long COVID to laboratory-based long COVID studies.
To ask the Scottish Government when it will publish its Rare Disease Action Plan.
To ask the Scottish Government whether it will grant an extension to businesses that were awarded grants through the COVID-19 Business Ventilation Fund but which did not receive notice from Dumfries and Galloway Council in time to have works carried out.
To ask the Scottish Government what role NHS boards have in monitoring the performance of dental practices treating NHS patients and the availability of NHS treatment.
To ask the Scottish Government what support is available to members of the public with a negligence claim against a solicitor.
To ask the Scottish Government how much funding it has made available for the creation and implementation of its Rare Disease Action Plan in (a) the current financial year and (b) each of the last five years.